| Pack Size/Qty | Price | Unit Price | |
| 100 Capsule/s | $95.00 | $0.96 | |
| 60 Capsule/s | $61.50 | $1.03 | |
| 30 Capsule/s | $33.60 | $1.12 |
Generic Name : Gabapentin
Brand Name : Neurontin
Manufacturer Name : Intas Pharmaceuticals Ltd.
Product Code : CRX 293
Delivery Days : 10 to 15 working days
Strength : 800 mg
Packaging : Capsules (Blister Packing)
Prescribed For : Diabetes Mellitus
Gabapin 800 mg is a pharmaceutical formulation that belongs to the anticonvulsant class of medications. Primarily composed of gabapentin as its active ingredient, Gabapin 800 mg is widely prescribed for the management of various neurological conditions, including epilepsy and neuropathic pain. This comprehensive description will delve into the pharmacology, indications, dosage, side effects, and precautions associated with Gabapin 800 mg.
Gabapin 800 mg exerts its therapeutic effects through the active ingredient gabapentin, which is a structural analog of the neurotransmitter gamma-aminobutyric acid (GABA). However, it does not interact directly with GABA receptors. Instead, gabapentin binds to the α2δ subunit of voltage-gated calcium channels in the central nervous system, particularly in the brain and spinal cord. By modulating calcium influx, Gabapin 800 mg reduces the release of excitatory neurotransmitters, inhibiting the abnormal neuronal activity associated with seizures and neuropathic pain.
Epilepsy: Gabapin 800 mg is indicated as an adjunctive therapy in the treatment of partial seizures with and without secondary generalization in adults and children over 12 years.
Neuropathic Pain: It is used to manage neuropathic pain conditions such as diabetic neuropathy, postherpetic neuralgia, and peripheral neuropathy.
The dosage of Gabapin 800 mg varies depending on the condition being treated. For epilepsy, the typical starting dose is 300 mg taken once on the first day, 300 mg twice daily on the second day, and 300 mg three times a day on the third day. The maintenance dose is then adjusted based on individual patient response. For neuropathic pain, the initial dose is 300 mg on the first day, 300 mg twice daily on the second day, and 300 mg three times a day on the third day. The maintenance dose may be increased to 600 mg or 800 mg three times a day based on patient response.
Gabapin 800 mg should be taken orally with or without food. It is crucial to follow the prescribed dosage and administration instructions provided by the healthcare professional to achieve optimal therapeutic outcomes.
Like any medication, Gabapin 800 mg may cause side effects. Common side effects include dizziness, drowsiness, peripheral edema, and fatigue. These side effects are usually mild and transient, resolving with continued use or dose adjustment. However, more serious side effects, such as allergic reactions, mood changes, and difficulty breathing, require immediate medical attention. Patients should report any unusual or severe side effects to their healthcare provider promptly.
Renal Impairment: Gabapin 800 mg is primarily eliminated by the kidneys, so dose adjustments are necessary in patients with renal impairment to prevent accumulation and potential toxicity.
Abrupt Discontinuation: Abruptly stopping Gabapin 800 mg can lead to withdrawal symptoms, including seizures. Therefore, it is crucial to follow the healthcare provider's guidance for discontinuation.
Pregnancy and Lactation: The safety of gabapentin during pregnancy and breastfeeding is not well-established. Pregnant or nursing women should consult their healthcare provider before using Gabapin 800 mg.
Driving and Operating Machinery: Due to the potential for dizziness and drowsiness, patients taking Gabapin 800 mg should exercise caution when driving or operating machinery.
Gabapin 800 mg is a valuable therapeutic option for individuals dealing with epilepsy and neuropathic pain. Its mechanism of action, dosage, and precautions highlight the importance of personalized medical guidance. This comprehensive description aims to provide a detailed understanding of Gabapin 800 mg, empowering patients and healthcare professionals alike with the knowledge needed for informed decision-making and safe medication management. As with any medication, open communication between patients and healthcare providers is crucial for optimizing treatment outcomes and ensuring patient well-being.